Wednesday, 26 August 2026European Markets

ASETEK Stock Was 10.84% Up Today

Loading stream...

(VIANEWS) - The Market ended the session with ASETEK (ASTK.OL) jumping 10.84% to kr9.20 on Thursday, after two consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.04% to kr1,216.15, after two sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

About ASETEK

Asetek A/S, together with its subsidiaries, engages in the designing, developing, and marketing of liquid cooling solutions in Asia, Europe, and the Americas. The company operates in two segments, Gaming and Enthusiast; and Data Center. Its products are used in personal computers, servers, and data centers to provide improved performance, acoustics, and energy efficiency. It serves original equipment manufacturers, resellers, and channel partners. Asetek A/S was founded in 1997 and is headquartered in Aalborg, Denmark.

Earnings Per Share

As for profitability, ASETEK has a trailing twelve months EPS of kr-3.29.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ASETEK's stock is considered to be overbought (>=80).

Volatility

ASETEK's last week, last month's, and last quarter's current intraday variation average was a negative 19.18%, a positive 4.72%, and a positive 7.07%.

ASETEK's highest amplitude of average volatility was 19.18% (last week), 13.46% (last month), and 7.07% (last quarter).

Volume

Today's last reported volume for ASETEK is 78760 which is 17.64% above its average volume of 66945.

More news about ASETEK (ASTK.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com